The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Nov. 04, 2016
Applicants:

Biogen International Neuroscience Gmbh, Zug, CH;

University of Zürich, Zürich, CA;

Inventors:

Roger Nitsch, Zumikon, CH;

Christoph Hock, Erlenbach, CH;

Maria Grazia Barenco Montrasio, Schindellegi, CH;

Fabio Montrasio, Schindellegi, CH;

Jan Grimm, Dubendorf, CH;

Jean-Luc Baeriswyl, Zurich, CH;

Paul Weinreb, Andover, MA (US);

Janaky Coomaraswamy, Zurich, CH;

Omar Quintero-Monzon, Waltham, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 49/16 (2006.01); A61K 51/10 (2006.01); C07K 16/18 (2006.01); G01N 33/68 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/3955 (2013.01); A61K 49/16 (2013.01); A61K 51/1018 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); G01N 2333/47 (2013.01); G01N 2800/2814 (2013.01);
Abstract

Provided are TAR DNA-binding protein of 43 kDa (TDP-43)-specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these TDP-43 specific binding molecules. Assays, kits, and solid supports related to TDP-43-specific binding molecules, including polypeptides such as, human antibodies are also disclosed. The TDP-43-specific binding molecule, antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for TDP-43 targeted immunotherapy and diagnosis, respectively.


Find Patent Forward Citations

Loading…